Stocklytics Platform
Asset logo for symbol TVTX
Travere Therapeutics
TVTX55
$22.91arrow_drop_down3.41%-$0.80
High Growth
Asset logo for symbol TVTX
TVTX55

$22.91

arrow_drop_down3.41%

Income Statement (TVTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$52.05M-$66.77M-$132.96M-$85.70M-$100.71M
EBITDA-$40.82M-$56.43M-$123.08M-$73.85M-$89.24M
gross Profit$61.27M$41.71M$39.87M$28.64M$35.80M
NET Income-$54.81M-$70.40M-$136.06M-$90.17M$150.73M
total Revenue$62.89M$54.11M$41.37M$45.05M$37.09M

Balance Sheet (TVTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$366.02M$370.93M$360.76M$346.60M$261.23M
stockholders Equity-$30.45M$15.14M$74.07M$200.81M$279.76M
total Assets$504.41M$551.12M$663.54M$788.91M$832.85M
total Debt$402.43M$403.22M$404.01M$404.78M$405.47M
total Liabilities$534.86M$535.97M$589.47M$588.10M$553.08M

Cash Flow (TVTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$46.00K$782.00K-$525.00K$124.00K-$634.00K
free Cash Flow-$23.76M-$52.23M-$125.47M-$76.00M-$64.69M
investing Cash Flow-----
operating Cash Flow-$42.50M-$40.24M-$119.00M-$70.47M-$59.13M

Travere Therapeutics (TVTX)

-
add Travere Therapeutics to watchlist

Keep an eye on Travere Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level